Abstract
Cystic Fibrosis (CF) is an autosomal recessive disease, caused by mutations in the Cystic Fibrosis Transmembrane Regulator gene (CFTR). The most frequent mutation in CF is ΔF508. The disease is clinically characterized by elevated concentrations of sweat chlorides and abnormally thick mucus. It affects organs such as lung, pancreas, gastrointestinal and reproductive tract. Women with CF commonly present delayed puberty and amenorrhea due to malnutrition. Our objective was to screen the presence of ΔF508 mutation in 24 women with altered fertility. Nine of these women presented reduced fertility without a known cause, four showed polycystic ovaries and two had early menopause. One woman with early menopause was a carrier of the ΔF508 mutation. Our study demonstrates that it is possible that the frequency of CF mutations among patients with altered fertility may be higher than expected. Previous data showed that fibrocystic women can show reduced fertility, maternal mortality associated with pregnancy and increased incidence of spontaneous abortion. We therefore recommend that women with reduced fertility undertake genetic tests for a better evaluation of pregnancy risks and clinical monitoring.
Similar content being viewed by others
References
Ratjen F, Doring G (2003) Cystic fibrosis. Lancet 361:681–689
Kerem B-S, Rommens JM, Buchanan JA et al (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073–1080
Riordan JR, Rommens JM, Kerem B-S et al (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066–1073
Rommens JM, Iannuzzi MC, Kerem BS (1989) Identification of Cystic Fibrosis gene: chromosome walking and jumping. Science 245:1059–1065
Stutts MJ, Canessa CM, Olsen JC, Hamrick M, Cohn JA, Rossier BC, Boucher RC (1995) CFTR as a cAMP-dependent regulator of sodium channels. Science 11:847–850
Sheppard DN, Welsh MJ (1999) Structure and function of the CFTR chloride channel. Physiol Rev 79:23–45
Reddy MM, Quinton PM (2001) Selective activation of cystic fibrosis transmembrane conductance regulator Cl− and HCO− conductances. JOP 2:212–218
Welsh MJ, Tsui LC, Boat TF et al (1995) Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 7th edn. McGraw-Hill, New York
Kosinska M, Szwed A, Cieslik J, Gozdzik J, Cofta S (2008) Biological status of adult patients with cystic fibrosis. J Physiol Pharmacol 59:341–348
Rozmahel R, Wilschaski M, Mãlin A (1996) Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet 12:280–287
Stead RJ, Hodson ME, Batten JC, Adams J, Jacobs HS (1987) Amenorrhoea in cystic fibrosis. Clin Endocrinol 26:187–195
Reiter EO, Stern RC, Root AW (1981) The reproductive endocrine system in cystic fibrosis. Am J Dis Child 135:422–426
Kopito LE, Kosasky HJ, Shwachman H (1973) Water and electrolytes in cervical mucus from patients with cystic fibrosis. Fertil Steril 24:512–516
Wang XF, Zhou CX, Shi QX, Yuan YY, Yu MK, Ajonuma LC, Ho LS, Lo PS, Tsang LS, Liu Y et al (2003) Involvement of CFTR in uterine bicarbonate secretion and the fertilizing capacity of sperm. Nature Cell Biol 5:902–906
Cohen LF, Di Sant’Agnese PA, Friedlander J (1980) Cystic fibrosis and pregnancy. A national survey. Lancet 2:842–844
Johannesson M, Gottlieb C, Hjelte L (1997) Delayed puberty in CF girls despite good clinical status. Pediatrics 99:29–34
Timmreck LS, Gray MR, Handelin B (2003) Analysis of cystic fibrosis transmembrane conductance regulator gene mutations in patients with congenital absence of the uterus and vagina. Am J Med Genet 1:72–76
Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual, 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
Kent NE, Farquharson DF (1993) Cystic fibrosis in pregnancy. Can Med Assoc J 149:809–813
Watson MS, Cutting GR, Desnick RJ, Driscoll DA, Klinger K, Mennuti M, Palomaki GE, Popovich BW, Pratt VM, Rohlfs EM et al (2004) Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med 6(5):387–391
Acknowledgments
G.V.F. Brunoro was supported by a HUCAM, scholarship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brunoro, G.V.F., Wolfgramm, E.V., Louro, I.D. et al. Cystic fibrosis Δf508 mutation screening in Brazilian women with altered fertility. Mol Biol Rep 38, 4343–4346 (2011). https://doi.org/10.1007/s11033-010-0560-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-010-0560-x